Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Heat Biologics Inc (NASDAQ: HTBX)

$0.77 USD -$0.01 (-1.28%)
Last Price $0.77
Net Change $-0.01 (-1.28%)
Bid $0
Ask Price $0
Open Price $0.79
Previous Close Price $0.78
High Price $0.79
Low Price $0.77
Number of Trades 555
Volume 238,300
Fifty Two Week High $3.35 (2016-11-29)
Fifty Two Week Low $0.4 (2016-05-13)
Average Daily Volume 1,105,068
Share Outstanding 33,530 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $11.27
Recent Earnings $
Annual EPS $-0.87
Last Quarter EPS $
Market Capitalization $0.03B
Insider Shareholders % 0.228%
Annual Revenue $0B
No. Shares Outstanding 33,530
Inst. Shareholder % 3.08%
Annual Net Income $0B
TTM Net Profit Margin $100.08
1-Year Return 13.24%
3-Year Return -87.17%
5-Year Return -91.95%
5-Year Revenue Growth 78.95%
5-Year Earnings Growth 97.22%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 11.27%
Dividends per Share $
Stock Split Ratio
Beta 0.82
Heat Biologics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of various cellular therapeutic vaccines for a range of cancers and infectious diseases. The Company's products under development include HS-110 for the treatment of non-small cell lung cancer, HS-410 for the bladder cancer treatment, HS-310 to treat ovarian cancer and HS-510 for treating triple negative breast cancer. Heat Biologics, Inc. is based in Chapel Hill, North Carolina.

HTBX News & Stock Updates